A Phase 1a/1b Multicentre, Open label, Dose escalation and Dose expansion Study to Evaluate the Safety, Pharmacokinetics, And Antitumor Activity of Ak104 in Subjects with Advanced Solid Tumours

  • Body, Amy (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date20/09/19 → 19/09/24

Keywords

  • clinical trial
  • phase 1 study
  • solid tumour
  • treatment efficacy
  • treatment safety